1. [Bone metabolism and fracture risk in anorexia nervosa].
- Author
-
Fernández Soto ML, González Jiménez A, and Varsavsky M
- Subjects
- Adipose Tissue metabolism, Adolescent, Adult, Anorexia Nervosa complications, Anorexia Nervosa drug therapy, Anorexia Nervosa therapy, Bone Density, Bone Density Conservation Agents therapeutic use, Bone Diseases, Metabolic drug therapy, Bone Diseases, Metabolic metabolism, Calcium therapeutic use, Cushing Syndrome etiology, Cushing Syndrome metabolism, Fractures, Bone etiology, Gonadal Steroid Hormones metabolism, Gonadal Steroid Hormones therapeutic use, Humans, Hypogonadism etiology, Hypogonadism metabolism, Intercellular Signaling Peptides and Proteins metabolism, Leptin physiology, Male, Osteoporosis drug therapy, Osteoporosis metabolism, Vitamin D therapeutic use, Young Adult, Anorexia Nervosa metabolism, Bone Diseases, Metabolic etiology, Bone and Bones metabolism, Fractures, Bone epidemiology, Minerals metabolism, Osteoporosis etiology
- Abstract
The prevalence of anorexia nervosa has increased in recent years and a large proportion of patients with this disorder have low bone density at diagnosis and, therefore, an increased risk of early and late fractures. The mechanism of bone loss in anorexia nervosa is not well understood, yet it likely includes hypogonadism, alterations of the GH-IGF-1 axis and hypercortisolism. DEXA is the most effective tool for assessing and monitoring bone density in these patients, and it is important to improve or at least stabilize bone metabolism in those with low bone mass. No agent has yet been proven to be effective in improving bone density. However, sustained weight recovery and menses besides an adequate intake of calcium and vitamin D are recommended to optimize the conditions in which bone mass accrual may occur., (Copyright © 2009 Elsevier España, S.L. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF